financing

News

Kidney biotech R1's $78m debut, and other biofinancings

Biofinancing values have tailed off a bit after a strong start to 2026, but March has seen $50m+ rounds for R1, Crossbow, Excalipoint, and Prolium.

News

Alto raises $120m for resistant depression programme

Alto Neuroscience has raised $120m that will fund pivotal trials of its recently acquired candidate for treatment-resistant depression.

News

Welsh firm Antiverse raises funds for AI antibody platform

Cardiff's Antiverse has raised $9.3m to develop its AI-based design platform for antibodies against hard-to-reach targets like GPCRs and ion channels.

News

Doctor listens through a stethoscope to a boy's breathing

ILiAD bags $115m for pertussis vaccine, and other financings

This week's biofinancings include a nine-figure round for ILiAD, with Quantx Bio, Aerska, Galux, and Pandorum Technologies also raising new funds.

News

Euro VCs team up to invigorate life sciences ecosystem

Major venture capital groups in Europe have joined forces to set up a new coalition aimed at revitalising access to life sciences investment.

News

Eikon, Veradermics close IPOs, as Salspera joins queue

Eikon and Veradermics push upsized IPOs over the line, as Salspera, which is developing live microbial immunotherapies for cancer, seeks a listing.

Kidney biotech R1's $78m debut, and other biofinancings

Alto raises $120m for resistant depression programme

Welsh firm Antiverse raises funds for AI antibody platform

ILiAD bags $115m for pertussis vaccine, and other financings

Euro VCs team up to invigorate life sciences ecosystem

Eikon, Veradermics close IPOs, as Salspera joins queue

Hernexeos and what’s next, with Vicky Brown

Using AI-driven synthetic personas to take your insights fur...

financing

Editor's Picks